Search

Your search keyword '"Marková J"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Marková J" Remove constraint Author: "Marková J"
150 results on '"Marková J"'

Search Results

53. Morphological-syntactic deficits in the production of Slovak-speaking aphasic patients.

55. Maintenance Optimization of Industrial Chimneys Exposed to Carbonation

56. Estimating Design Resistance of Wrought Balcony Girders

57. Uncertainty in Crack width Estimates According to Fib Model Code 2010

58. Analysis of Partial Factors for New EN 1990 Basis of Design

59. Reliability Assessment of Quick Closing Valves in Hydroeletric Power Plant

60. Monitoring of water quality of selected wells in Brno district

61. Primary manifestation of Hodgkin's disease in the central nervous system.

63. The Role of Endophytic Microorganisms of Medicinal Plants in the Adaptation of Host Plant

64. Conservation paradox of giant arapaima Arapaima gigas (Schinz, 1822) (Pisces: Arapaimidae): endangered in its native range in Brazil and invasive in Indonesia

65. Target Reliability Levels in Present Standards

72. The Monitoring of selected sources in the administration of the Forests of Brno

74. Wildlife as Reservoirs of Encephalitozoon Cuniculi and Encephalitozoon Hellem and Molecular Genotyping of Encephalitozoon spp. in Small Mammals in the Czech Republic.

75. Effect of Age and Education on Discourse Cohesion.

76. A novel germline hyperactivating JAK2 mutation L604F.

77. Comparative Characterization of Immune Response in Sheep with Caseous Lymphadenitis through Analysis of the Whole Blood Transcriptome.

78. Molecular Detection of Toxoplasma gondii , Neospora caninum and Encephalitozoon spp. in Vespertilionid Bats from Central Europe.

79. NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia.

80. Wild Small Mammals and Ticks in Zoos-Reservoir of Agents with Zoonotic Potential?

81. Biosurveillance of Selected Pathogens with Zoonotic Potential in a Zoo.

82. Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations.

83. Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer's disease.

84. Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia.

85. Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials.

86. Detection of antibodies to Borrelia burgdorferi s.l. in wild small mammals and sensitivity of PCR and cultivation.

87. Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG).

88. Molecular Evidence of Toxoplasma gondii, Neospora caninum, and Encephalitozoon cuniculi in Red Foxes ( Vulpes vulpes).

89. Sentence comprehension in Slovak-speaking patients with Alzheimer's disease.

90. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].

91. [Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].

92. Prevalence of antibodies to Encephalitozoon cuniculi in European hares (Lepus europaeus).

93. CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.

94. [Treatment and prognosis of relapsed or refractory Hodgkin lymphoma patients ineligible for stem cell transplantation].

96. [The role of radiotherapy in the treatment of malignant lymphomas - recommendations of the Czech Lymphoma Study Group].

97. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.

98. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.

99. Estimation of molecular upper remission limit for monitoring minimal residual disease in peripheral blood of acute myeloid leukemia patients by WT1 expression.

100. [Treatment of patients with relapsed/refractory Hodgkin lymphoma].

Catalog

Books, media, physical & digital resources